Skip to main content

About
Clinical Need
Technology
- Hu-PHEC
- CDX Antibodies
Pipeline
News
Investors
Join Us
Contact

News

About
Clinical Need
Technology
- Hu-PHEC
- CDX Antibodies
Pipeline
News
Investors
Join Us
Contact

Press releases

Media

@Hemogenyx

Hemogenyx

View All >

A new era for the treatment of blood diseases

Our aim is to change the way in which bone marrow/hematopoietic stem cell transplants are performed and improve their efficacy.

About Us

Hemogenyx is developing breakthrough therapies for the treatment of blood diseases

Uk Headquarters

5 Fleet Place,
London, EC4M 7RD, United Kingdom

Research Facility

760 Parkside Ave., Suite 212
Brooklyn, NY 11226, USA

Contact Us

© Hemogenyx Pharmaceuticals plc 2017-. All rights reserved. Hemogenyx Pharmaceuticals plc is registered in England and Wales as company number 08401609 at 5 Fleet Place, London EC4M 7RD, UK

Powered By Q4 Inc. 5.19.0.3 (opens in new window)